Sarissa Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.4M Sell
15,919,435
-470,565
-3% -$337K 7.4% 5
2025
Q1
$24.1M Hold
16,390,000
15.57% 4
2024
Q4
$72.6M Hold
16,390,000
22.49% 2
2024
Q3
$67.5M Hold
16,390,000
16.78% 2
2024
Q2
$107M Hold
16,390,000
18.04% 3
2024
Q1
$143M Hold
16,390,000
24.97% 1
2023
Q4
$188M Hold
16,390,000
28.9% 1
2023
Q3
$158M Hold
16,390,000
21.26% 3
2023
Q2
$174M Hold
16,390,000
17.36% 3
2023
Q1
$172M Hold
16,390,000
22.05% 3
2022
Q4
$203M Hold
16,390,000
24.17% 2
2022
Q3
$170M Hold
16,390,000
19.19% 3
2022
Q2
$189M Hold
16,390,000
19.02% 2
2022
Q1
$206M Hold
16,390,000
19.49% 2
2021
Q4
$191M Hold
16,390,000
16.54% 3
2021
Q3
$214M Hold
16,390,000
16.8% 2
2021
Q2
$211M Hold
16,390,000
16.77% 3
2021
Q1
$183M Buy
16,390,000
+2,350,000
+17% +$26.3M 17.56% 1
2020
Q4
$160M Hold
14,040,000
16.32% 1
2020
Q3
$126M Hold
14,040,000
14.87% 4
2020
Q2
$145M Buy
14,040,000
+515,000
+4% +$5.31M 16.12% 3
2020
Q1
$136M Buy
13,525,000
+3,218,000
+31% +$32.5M 17.41% 2
2019
Q4
$137M Buy
10,307,000
+204,000
+2% +$2.72M 11.39% 3
2019
Q3
$86.7M Buy
10,103,000
+385,000
+4% +$3.31M 10.87% 4
2019
Q2
$106M Buy
9,718,000
+712,613
+8% +$7.8M 13.25% 4
2019
Q1
$102M Buy
9,005,387
+1,540,141
+21% +$17.5M 15.36% 3
2018
Q4
$64.8M Buy
7,465,246
+3,444,929
+86% +$29.9M 14.35% 4
2018
Q3
$62.2M Hold
4,020,317
13.71% 4
2018
Q2
$64.4M Hold
4,020,317
12.91% 3
2018
Q1
$52M Buy
4,020,317
+2,050,217
+104% +$26.5M 12.02% 5
2017
Q4
$24.7M Buy
+1,970,100
New +$24.7M 6.33% 6